Background Azithromycin mass drug administration (MDA) to ages 1–59 months can reduce childhood mortality; however, more ...

A randomized controlled trial found that patients hospitalized for an acute exacerbation of chronic obstructive poulmonary disease (COPD) experienced reduced rates of treatment failure when adding ...

An extended course of low-dose azithromycin (multiple brands) may significantly reduce treatment failure in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease (COPD) ...

May 3, 2019--The antibiotic azithromycin may reduce treatment failure in patients hospitalized for an acute exacerbation of chronic obstructive pulmonary disease (COPD), according to a randomized, ...

Mass treatment with azithromycin is a central component of the new World Health Organization (WHO) strategy to eradicate yaws. Empirical data on the effectiveness of the strategy are required as a ...

SAN DIEGO, CA— At IDWeek 2012, researchers presented that the addition of azithromycin to ceftriaxone therapy for children hospitalized with community-acquired pneumonia (CAP) was not associated with ...

Trachoma, an infectious keratoconjunctivitis caused by Chlamydia trachomatis, is a leading cause of preventable blindness in developing countries. In this study we compared oral azithromycin with ...

The adjunctive use of antibiotics such as metronidazole (MTZ) or amoxicillin (AMX) during periodontal treatment has been shown to offer short-term benefits (Journal of Clinical Periodontology, April ...

Please provide your email address to receive an email when new articles are posted on . Long-term azithromycin treatment increased lumen radius and lumen area in patients with severe persistent asthma ...

Azithromycin has been suggested as a possible COVID treatment, but clinicians should be aware of the drug’s potential to cause heart problems when taken with commonly used medications, researchers ...